FDA
approval
· 2022-11-23
FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
Summary
The FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NOVOLIN N (HUMAN INSULIN)